Back to Search
Start Over
Latest preclinical study suggests broader potential utility of MDM2 antisense
- Source :
- Proteomics Weekly. March 22, 2004, 21
- Publication Year :
- 2004
-
Abstract
- 2004 MAR 22 - (NewsRx.com & NewsRx.net) -- Hybridon, Inc., (HBY) announced the publication of a preclinical research report presenting evidence in cells and cell lysates that the MDM2 oncoprotein [...]
- Subjects :
- Hybridon Inc.
Cytology
Biotechnology industry
Biotechnology industry
Business
Subjects
Details
- Language :
- English
- ISSN :
- 15352722
- Database :
- Gale General OneFile
- Journal :
- Proteomics Weekly
- Publication Type :
- News
- Accession number :
- edsgcl.114418442